Rita Silberberg
NAOVAbout Rita Silberberg
Rita Silberberg, age 49, was appointed Executive Vice President of Finance and Chief Accounting Officer (and Corporate Secretary) of NanoVibronix on July 24, 2025. She holds an LL.B in Law and a B.A. in Business with an Accounting specialization (College of Management, 1999), and brings 15+ years of corporate finance leadership across US GAAP/IFRS and cross‑border compliance; prior roles include CFO of Gravity Creative Space (2013–2022) and Director of Finance/Project Manager at Ernst & Young (2002–2005) . Company operating context since her appointment: Q3 2025 revenue was $722k (up ~92% YoY) and net income was $510k, though the company disclosed substantial doubt about its ability to continue as a going concern over the next twelve months . NanoVibronix prohibits hedging and pledging by officers under its insider trading policy, reducing misalignment risks .
Past Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| Gravity Creative Space | Chief Financial Officer | 2013–2022 | Led budgeting, strategic growth, and international tax for a global post‑production/VFX business . |
| Ernst & Young | Director of Finance & Project Manager | 2002–2005 | Managed multi‑disciplinary engagements and finance operations for international clients . |
| ENvue Medical Israel Ltd. | Finance leadership | 2022–2025 | Supported finance function ahead of ENvue combination with NanoVibronix . |
External Roles
No public-company directorships or committee roles disclosed for Ms. Silberberg .
Fixed Compensation
| Component | Terms | Effective Date | Notes |
|---|---|---|---|
| Base Salary | NIS 44,000 gross per month, increasing to NIS 68,750 upon milestone completion | Feb 12, 2025 (ENvue employment agreement) | Agreement includes “customary incidental payments and expenses” . |
| Indemnification | Expected to enter company’s standard officer indemnification agreement | July 24, 2025 | Company disclosure of expected indemnification for officers . |
No target bonus %, actual bonus, or cash retainer disclosures for Ms. Silberberg in NanoVibronix’s proxy or 10‑Q; 2024 NEO tables cover CEO/CFO only, not Ms. Silberberg .
Performance Compensation
| Metric | Weighting | Target | Actual | Payout | Vesting |
|---|---|---|---|---|---|
| Not disclosed | Not disclosed | Not disclosed | Not disclosed | Not disclosed | Not disclosed |
Company’s 2024 Long‑Term Incentive Plan permits performance awards tied to criteria such as revenues, EBITDA, EPS, gross margin, total shareholder return, market share, and cash flow, but no individual award terms for Ms. Silberberg are disclosed .
Equity Ownership & Alignment
- Beneficial ownership: Ms. Silberberg is not listed among directors or named executive officers in the Security Ownership table (as of Oct 27, 2025 record date); no personal holdings disclosed .
- Options/RSUs: No grants or holdings disclosed for Ms. Silberberg in the proxy or 10‑Q .
- Hedging/pledging: Company policy prohibits officers from hedging or pledging company securities; no exemptions granted .
- Stock ownership guidelines: Not disclosed in the proxy .
- Vested vs. unvested: Not disclosed .
Employment Terms
| Term | Detail | Source |
|---|---|---|
| Appointment | EVP Finance & Chief Accounting Officer and Corporate Secretary, effective July 24, 2025 | |
| ENvue Employment Agreement | ENvue agreement dated Feb 12, 2025 governs salary (NIS 44,000 → NIS 68,750 upon milestones) and “customary incidental payments” | |
| Termination | Agreement may be terminated by either party per terms; ENvue may terminate for “Cause” upon notice with immediate effect | |
| Covenants | Confidentiality and privacy covenants | |
| Company agreement | Company expects Ms. Silberberg to enter NanoVibronix employment agreement and standard officer indemnification |
Severance, change‑of‑control triggers, clawback application to individual awards, non‑compete/non‑solicit scope, and vesting schedules are not disclosed for Ms. Silberberg .
Investment Implications
- Alignment and selling pressure: Lack of disclosed equity awards or option holdings for Ms. Silberberg reduces immediate insider selling pressure signals; anti‑hedging/anti‑pledging policy further curbs misalignment risk .
- Retention risk: Role elevation amid ENvue integration and company going‑concern disclosure heightens organizational execution risk; ENvue agreement’s milestone‑based salary increase indicates targeted retention incentives but no severance/change‑of‑control terms are disclosed, limiting visibility on downside protection .
- Pay‑for‑performance visibility: Company maintains a performance‑capable equity plan, but no individual performance weightings, targets, or payouts are disclosed for Ms. Silberberg, reducing clarity on pay‑for‑performance alignment at the officer level .
- Operating backdrop: Q3 2025 showed 92% YoY revenue growth to $722k and net income of $510k, yet the nine‑month period remained loss‑making with material financing dependencies—finance leadership stability is critical for integration, capital access, and controls remediation .
Governance context: Compensation Committee oversight is in place (independent directors), and the next say‑on‑pay vote is expected in 2027, limiting near‑term shareholder feedback on executive compensation structure .